In vitro virus propagation and high cellular responsiveness to the infected cells in patients with HTLV-I-associated myelopathy (HAM/TSP)

Journal of the Neurological Sciences

Volumn 149, Issue 2, 1997, Pages 141-145

  Machigashira, Koichi ^a,c   Ijichi, Shinji ^a   Nagai, Masahiro ^a   Yamano, Yoshihisa ^a   Hall, William W ^b   Osame, Mitsuhiro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b ROCKEFELLER UNIVERSITY   (United States)

^c Nagahama Shinryojyo   (Japan)

Author keywords

Asymptomatic HTLV I carriers; HTLV I associated myelopathy tropical spastic paraparesis (HAM TSP); Human T lymphocyte virus type I (HTLV I); Pathomechanism

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS; LYMPHOCYTE; MALE; PRIORITY JOURNAL; SPASTIC PARESIS; SPINAL CORD DISEASE;

ADULT; AGED; ANTIGENS, VIRAL; CARRIER STATE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; FEMALE; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MALE; MIDDLE AGED; PARAPARESIS, TROPICAL SPASTIC;

EID: 0030957041     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)05360-4     Document Type: Article

References (38)

1. Bangham, C.R.M. (1993) Human T-cell leukaemia virus type I and neurological disease. Curr. Opin. Neurobiol., 3: 773-778.
2. Ceroni, M., Piccardo, P., Rodgers-Johnson, P., Mora, C., Asher, D.M., Gajdusek, C. and Gibbs, C.J. (1988) Intrathecal synthesis of IgG antibodies to HTLV-I supports an etiological role for HTLV-I in tropical spastic paraparesis. Ann. Neurol., 23 (Suppl): 5188-5191.
3. Gazzolo, L. and Due Dodon, M. (1987) Direct activation of resting T lymphocytes by human T-lymphotropic virus type I. Nature, 326: 714-717.
4. Gessain, A., Saal, F., Gout, O., Daniel, M.-T., Flandrin, G., De The, G., Peries, J. and Sigaux, F. (1990) High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis. Blood, 75: 428-433.
5. Gessain, A. and Gout, O. (1992) Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I). Ann. Intern. Med., 117: 933-946.
6. Grimaldi, L.M.E., Roos, R.P., Devare, S.G., Casey, J.M., Maruo, Y., Hamada, T. and Tashiro, K. (1988) HTLV-I-associated myelopathy: oligoclonal immunoglobulin G bands contain anti-HTLV-I p24 antibody. Ann. Neurol., 24: 727-731.
7. Hara, H., Morita, M., Iwaki, T., Hatae, T., Itoyama, Y., Kitamoto, T., Akizuki, S., Goto, I. and Watanabe, T. (1994) Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor Vß CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis. J. Exp. Med., 180: 831-839.
8. Hinuma, Y., Gotoh, Y., Sugamura, K., Nagata, K., Goto, T., Nakai, M., Kamada, N., Matsumoto, T. and Kinoshita, K. (1982) A retrovirus associated with human adult T-cell leukemia: in vitro activation. Gann, 73: 341-344.
9. Höllsberg, P. and Hafler, D. A. (1993) Pathogenesis of diseases induced by human lymphotropic virus type I infection. New Engl. J. Med., 328: 1173-1182.
10. Ijichi, S. and Osame, M. (1995) Human T lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/ TSP): recent perspectives. Intern. Med., 34: 713-721.
11. Jacobson, S., Shida, H., McFarlin, D.E., Fauci, A.S. and Koenig, S. (1990) Circulating CD8+ cytotoxic T lymphocyte specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature, 348: 245-248.
12. Kannnagi, M., Harada, S., Maruyama, I., Inoko, H., Igarashi, H., Kuwashima, G., Sato, S., Morita, M., Kidokoro, M., Sugimoto, M., Funahashi, S., Osame, M. and Shida, H. (1991) Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. Int. Immunol., 3: 761-767.
13. Kaplan, J.E., Osame, M., Kubota, H., Igata, A., Nishitani, H., Maeda, Y., Khabbaz, R.F. and Janssen, R.S. (1990) The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J. Acquired Immune Defic. Syndr., 3: 1096-1101.
14. Kashio, N., Izumo, S., Ijichi, S., Hashimoto, K., Umehara, F., Higuchi, I. and Osame, M. (1994) Detection of HTLV-I provirus by in situ polymerase chain reaction in mononuclear cells infiltrating spinal cord lesions from HAM/TSP patients. Brain Pathol., 4: 498 (abstract).
15. Kira, J., Koyanagi, Y., Yamada, T., Itoyama, Y., Goto, I., Yamamoto, N., Sasaki, H. and Sakaki, Y. (1991) Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study. Ann. Neurol., 29: 194-201.
16. Kira, J., Nakamura, M., Sawada, T., Koyanagi, Y., Ohori, N., Itoyama, Y., Yamamoto, N., Sakaki, Y. and Goto, I. (1992) Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load. J. Neurol. Sci., 107: 98-104.
17. Kondo, T., Kono, H., Miyamoto, N., Yoshida, R., Toki, H., Matsumoto, I., Hara, M., Inoue, H., Inatsuki, A., Funatsu, T., Yamano, N., Bando, F., Iwao, E., Miyoshi, I., Hinuma, Y. and Hanaoka, M. (1989) Age-and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. Int. J. Cancer, 43: 1061-1064.
18. Kubota, R., Umehara, F., Izumo, S., Ijichi, S., Matsumuro, K., Yashiki, S., Fujiyoshi, T., Sonoda, S. and Osame, M. (1994) HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy. J. Neuroimmunol., 53: 23-29.
19. Kuroda, Y., Matsui, M., Kikuchi, M., Kurohara, K., Endo, C., Yukitake, M., Matsuda, Y., Tokunaga, O., Komine-Sakaki, A. and Kawaguchi, R. (1994) In situ demonstration of the HTLV-I genome in the spinal cord of a patient with HTLV-I-associated myelopathy. Neurology, 44: 2295-2299.
20. Lehky, T.J., Fox, C.H., Koenig, S., Levin, M.C., Flerlage, N., Izumo, S., Sato, E., Raine, C.S., Osame, M. and Jacobson, S. (1995) Detection of human T-lymphotropic virus type I (HTLV-I) Tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann. Neurol., 37: 167-175.
21. Matsumoto, M., Sugimoto, M., Nakashima, H., Imamura, F., Kawano, O, Uyama, E., Takatsu, K. and Araki, S. (1990) Spontaneous T cell proliferation and release of soluble interleukin-2 receptors in patients with HTLV-I-associated myelopathy. Am. J. Trop. Med. Hyg., 42: 365-373.
22. Minato, S., Itoyama, Y., Goto, I. and Yamamoto, N. (1988) Expression of HTLV-I antigen in cultured peripheral blood mononuclear cells from patients with HTLV-I associated myelopathy. J. Neurol. Sci., 87: 233-244.
23. Moore, G.R.W., Traugott, U., Scheinberg, L.C. and Raine, C.S. (1989) Tropical spastic paraparesis: a model of virus-induced, cytotoxic T-cell-mediated demyelination? Ann. Neurol., 26: 523-530.
24. + T-lymphocytes. Ann. Neurol. 40: 84-90.
25. Nagasato, K., Nakamura, T., Shirabe, S., Shibayama, K., Ohishi, K., Ichinose, K., Tsujihata, M. and Nagataki, S. (1991) Presence of serum anti-human T-lymphotropic virus type I (HTLV-I) IgM antibodies means persistent active replication of HTLV-I in HTLV-I-associated myelopathy. J. Neurol. Sci., 103: 203-208.
26. Nishimura, M., Adachi, A., Akiguchi, I., Shirahata, N., Maeda, M., Ishimoto, A., Mezaki, T. and Kimura, J. (1990) High ratio of HTLV-I-infected cells in HTLV-I associated myelopathy (HAM). Acta. Neurol. Scand., 81: 209-214.
27. Okamoto, T., Ohno, Y., Tsugane, S., Watanabe, S., Shimoyama, M., Tajima, K., Miwa, M. and Shimotohno, K. (1989) Multi-step carcinogenesis model for adult T-cell leukemia. Jpn. J. Cancer Res., 80: 191-195.
28. Osame, M., Janssen, R., Kubota, H., Nishitani, H., Igata, A., Nagataki, S., Mori, M., Goto, I., Shimabukuro, H., Khabbaz, R. and Kaplan, J. (1990) Nationwide survey of HTLV-I-associated myelopathy in Japan: association with blood transfusion. Ann. Neurol., 28: 50-56.
29. Osame, M. and McArthur, J.C., Neurologic manifestations of infection with human T cell lymphotropic virus type I. In: Asbury, A.K., McKhann G.M. and McDonald W.I. (Eds.), Diseases of the nervous system: clinical neurobiology, Vol. II, W.B. Saunders, Philadelphia, 1992, pp. 1331-1339.
30. Richardson, J.H., Edwards, A.J., Cruickshank, J.K., Rudge, P. and Dalgleish, A.G. (1990) In vivo cellular tropism of human T-cell leukemia virus type I. J. Virol., 64: 5682-5687.
31. Rosenblatt, J.D., Chen, I.S.Y., and Wachsman, W. (1988) Infection with HTLV-I and HTLV-II: evolving concepts. Semin. Hematol., 25: 230-246.
32. Sugamata, M., Miyazawa, M., Mori, S., Spangrude, G.J., Ewalt, L.C., and Lodmell, D.L. (1992) Paralysis of street rabies virus-infected mice is dependent on T lymphocytes. J. Virol., 66: 1252-1260.
33. Usuku, K., Sonoda, S., Osame, M., Yashiki, S., Takahashi, K., Matsumoto, M., Sawada, T., Tsuji, K., Tara, M., and Igata, A. (1988) HLA haplotyoe-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma. Ann. Neurol., 23 (Suppl): 5143-5150.
34. Wang, F.-I., Stohlman, S.A. and Fleming, J.O. (1990) Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated. J. Neuroimmunol., 30: 31-41.
35. Wekerle, H. and Ketelsen, U.-P. (1977) Intrathymic pathogenesis and dual genetic control of myasthenia gravis. Lancet, 1: 678-680.
36. World Health Organization. (1989) Virus diseases: human T-lymphotropic virus type I, HTLV-I (abstract). WHO Weekly Epidemiol. Rec., 49: 382-383.
37. Yamada, M., Zurbringgen, A. and Fujinami, R.S. (1990) The relationship between viral RNA, myelin-specific mRNAs, and demyelination in central nervous system disease during Theiler's virus infection. Am. J. Pathol., 137: 1467-1479.
38. Yoshida, M., Osame, M., Kawai, H., Toita, M., Kuwasaki, N., Nishida, Y., Hiraki, Y., Takahashi, K., Nomura, K., Sonoda, S., Eiraku, N., Ijichi, S. and Usuku, K. (1989) Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann. Neurol., 26: 331-335.